The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data-Reference-Cited by-同舟云学术

The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data

Published:2015-03-06 Issue:3 Volume:40 Page:273-278
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Hagiwara Hiromi¹,Nakano Shun¹,Ogawa Yoshihiro¹,Tohkin Masahiro¹

Affiliation:

1. Department of Regulatory Science; Graduate School of Pharmaceutical Sciences; Nagoya City University; Nagoya Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12256/fullpdf

Reference21 articles.

1. Pharmaceuticals and Medical Devices Agency, Japan Post-marketing Safety:Outline http://www.pmda.go.jp/english/about/pdf/profile_of_services.pdf

2. Pharmaceuticals and Medical Devices Agency, Japan Post-marketing Safety:Safety Information http://www.pmda.go.jp/english/service/safety_info.html

3. Pharmaceuticals and Medical Devices Agency, Japan The Yellow Letter/Blue Letter http://www.pmda.go.jp/english/service/letter.html

4. Pharmaceuticals and Medical Devices Agency, Japan Pharmaceuticals and Medical Devices Safety Information http://www.pmda.go.jp/english/service/precautions.html

5. Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of ‘Dear Doctor’ letters;Weatherby;Pharmacoepidemiol Drug Saf,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method;Journal of Healthcare Engineering;2020-02-14

2. Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review;Drug Safety;2020-02-04

3. A review of studies using the Japanese National Database of Health Insurance Claims and Specific Health Checkups;Annals of Clinical Epidemiology;2020

4. Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations;British Journal of Clinical Pharmacology;2017-12-20

5. The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products;Drug Safety;2017-12-07